RT @ilyapharma: First clinical trial with #ILP100 #emilimogene #sigulactibac published!
#RCT #Lancet #Discovery #eclinicalmedicine #ATMP #CGT #synbio #innovation #H2020 #EICAccelerator https://t.co/QU5Z0Ri8zn
π¦π: https://n.respublicae.eu/EUeic/status/1664527874638987264
Mia Phillipson on Twitter
βAm super proud of this innovative approach enabling the use of short-lived chemokines to treat disease. And of the team making this possible. Thank you,thank you,thank you! @KAWstiftelsen @ilyapharma @scilifelab @stiftelse @uppsalauni @_SLU @H2020Projects https://t.co/7EdwI7oEqIβ